Format

Send to

Choose Destination
Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10.

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Author information

1
University of Washington, Seattle, WA, USA graghu@u.washington.edu.
2
University of Utah, Salt Lake City, UT, USA.
3
University of Alabama at Birmingham, Birmingham, AL, USA.
4
Vanderbilt University, Nashville, TN, USA.
5
University of Vermont, Burlington, VT, USA.
6
David Geffen School of Medicine, Los Angeles, CA, USA.
7
National Jewish Health, Denver, CO, USA.
8
University of Michigan Health System, USA.
9
Via Christi Clinic, Wichita, KS, USA.
10
Pulmonary Function and Clinical Trial Consultant, Rochester, MN, USA.
11
FibroGen, Inc., San Francisco, CA, USA.

Abstract

FG-3019 is a fully human monoclonal antibody that interferes with the action of connective tissue growth factor, a central mediator in the pathogenesis of fibrosis.This open-label phase 2 trial evaluated the safety and efficacy of two doses of FG-3019 administered by intravenous infusion every 3 weeks for 45 weeks in patients with idiopathic pulmonary fibrosis (IPF). Subjects had a diagnosis of IPF within the prior 5 years defined by either usual interstitial pneumonia (UIP) pattern on a recent high-resolution computed tomography (HRCT) scan, or a possible UIP pattern on HRCT scan and a recent surgical lung biopsy showing UIP pattern. Pulmonary function tests were performed every 12 weeks, and changes in the extent of pulmonary fibrosis were measured by quantitative HRCT scans performed at baseline and every 24 weeks.FG-3019 was safe and well-tolerated in IPF patients participating in the study. Changes in fibrosis were correlated with changes in pulmonary function.Further investigation of FG-3019 in IPF with a placebo-controlled clinical trial is warranted and is underway.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01262001.

PMID:
26965296
DOI:
10.1183/13993003.01030-2015
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center